# Pemetrexed &Oxaliplatin in Patients w Recurrent NSCLCa After Failure to Platinum Based Adjuvant Chem

> **NCT00612677** · PHASE2 · TERMINATED · sponsor: **H. Lee Moffitt Cancer Center and Research Institute** · enrollment: 1 (actual)

## Conditions studied

- Lung Cancer

## Interventions

- **DRUG:** Oxaliplatin
- **DRUG:** Pemetrexed

## Key facts

- **NCT ID:** NCT00612677
- **Lead sponsor:** H. Lee Moffitt Cancer Center and Research Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2007-06
- **Primary completion:** 2008-01
- **Final completion:** 2008-01
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** slow accrual - the 1 patient accrued did not go on treatment
- **Last updated:** 2017-03-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00612677

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00612677, "Pemetrexed &Oxaliplatin in Patients w Recurrent NSCLCa After Failure to Platinum Based Adjuvant Chem". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00612677. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*